Theseus Pharmaceuticals, Inc.
THRXDelisted Feb 14, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745020
Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Theseus Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- 0 vs. Q2 2022
- Shares held
- 34.6M
- −60.7K (−0.2%) vs. Q2 2022
- Total value
- $200.7M
- +$9.08M (+4.7%) vs. Q2 2022
- New holders
- 2
- 17 more added
- Sold out
- 2
- 12 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 70 | $145.8M |
| Q3 2023 | 63 | $95.5M |
| Q2 2023 | 69 | $373.6M |
| Q1 2023 | 72 | $350.6M |
| Q4 2022 | 47 | $164.8M |
| Q3 2022 | 51 | $200.7M |
| Q2 2022 | 51 | $191.6M |
| Q1 2022 | 47 | $402.8M |
| Q4 2021 | 46 | $441.4M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Theseus Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 32 | $0 | 0.00% | −141−81.5% | Reduced |
| Castle Wealth Management LLC | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 257 | $1.00K | 0.00% | −916−78.1% | Reduced |
| Royal Bank of Canada | 206 | $1.00K | 0.00% | +110+114.6% | Added |
| Credit Suisse AG | 94 | $1.00K | 0.00% | +80+571.4% | Added |
| Ameritas Investment Partners, Inc. | 889 | $5.00K | 0.00% | 00.0% | Unchanged |
| High Net Worth Advisory Group LLC | 800 | $5.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,433 | $8.00K | 0.00% | −529−27.0% | Reduced |
| Amalgamated Bank | 1,901 | $11.0K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 2,700 | $15.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,420 | $26.0K | 0.00% | +1,757+66.0% | Added |
| Barclays PLC | 5,060 | $29.0K | 0.00% | −132−2.5% | Reduced |
| Bank of America Corp | 5,895 | $35.0K | 0.00% | −499−7.8% | Reduced |
| California State Teachers Retirement System | 6,707 | $39.0K | 0.00% | −559−7.7% | Reduced |
| American International Group, Inc. | 8,066 | $47.0K | 0.00% | +114+1.4% | Added |
| Morgan Stanley | 8,757 | $51.0K | 0.00% | −3,876−30.7% | Reduced |
| JPMorgan Chase & Co | 9,159 | $53.0K | 0.00% | +75+0.8% | Added |
| Deutsche Bank AG | 9,410 | $55.0K | 0.00% | −1,139−10.8% | Reduced |
| New York State Common Retirement Fund | 9,551 | $55.0K | 0.00% | +56+0.6% | Added |
| Forefront Analytics, LLC | 13,065 | $74.0K | 0.04% | +13,065 | New |
| BNP Paribas Arbitrage, SA | 15,310 | $88.8K | 0.00% | +15,310 | New |
| Rhumbline Advisers | 24,848 | $144.0K | 0.00% | +1,443+6.2% | Added |
| Nuveen Asset Management, LLC | 36,636 | $212.0K | 0.00% | +4,918+15.5% | Added |
| Bank of New York Mellon Corp | 43,144 | $250.0K | 0.00% | +4,333+11.2% | Added |
| Charles Schwab Investment Management Inc | 43,327 | $252.0K | 0.00% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 55,883 | $340.7K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 79,398 | $461.0K | 0.01% | +47,679+150.3% | Added |
| DAFNA Capital Management LLC | 81,899 | $475.0K | 0.13% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 100,000 | $580.0K | 0.02% | 00.0% | Unchanged |
| TD Asset Management Inc | 106,948 | $652.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 133,555 | $775.0K | 0.00% | +5,495+4.3% | Added |
| Ensign Peak Advisors, Inc | 142,598 | $827.0K | 0.00% | 00.0% | Unchanged |
| Wellington Management Group LLP | 172,566 | $1.00M | 0.00% | +112,411+186.9% | Added |
| Laurion Capital Management LP | 179,619 | $1.04M | 0.03% | 00.0% | Unchanged |
| Opaleye Management Inc. | 220,650 | $1.28M | 0.53% | +188,350+583.1% | Added |
| Farallon Capital Management, L.L.C. | 223,149 | $1.29M | 0.01% | −186,568−45.5% | Reduced |
| Woodline Partners LP | 236,390 | $1.37M | 0.02% | +24,706+11.7% | Added |
| State Street Corp | 248,281 | $1.44M | 0.00% | +14,388+6.2% | Added |
| Geode Capital Management, LLC | 287,395 | $1.67M | 0.00% | +31,256+12.2% | Added |
| Rock Springs Capital Management LP | 437,329 | $2.54M | 0.07% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 504,862 | $2.93M | 2.64% | 00.0% | Unchanged |
| Nextech Invest AG | 611,310 | $3.55M | 1.15% | 00.0% | Unchanged |
| Vanguard Group Inc | 625,943 | $3.63M | 0.00% | −3,371−0.5% | Reduced |
| Omega Fund Management, LLC | 711,479 | $4.13M | 1.51% | 00.0% | Unchanged |
| BlackRock Inc. | 775,590 | $4.50M | 0.00% | +88,231+12.8% | Added |
| Boxer Capital, LLC | 892,057 | $5.17M | 0.29% | 00.0% | Unchanged |
| Foresite Capital Opportunity Management V, LLC | 959,275 | $5.56M | 16.71% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 1,381,489 | $8.01M | 0.00% | −3,794−0.3% | Reduced |
| Foresite Capital Management V, LLC | 3,335,346 | $19.3M | 14.87% | 00.0% | Unchanged |
| FMR LLC | 4,803,240 | $27.9M | 0.00% | −380,123−7.3% | Reduced |
| OrbiMed Advisors LLC | 17,041,668 | $98.8M | 1.96% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −22,402−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −10,412−100.0% | Sold out |